FDA In Brief > FDA In Brief: FDA updates public information about known risk of lymphoma from breast implants

FDA In Brief > FDA In Brief: FDA updates public information about known risk of lymphoma from breast implants



FDA In Brief: FDA updates public information about known risk of lymphoma from breast implants

Today, the FDA is communicating updated information about its understanding of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Continue reading.